Skip to content
DAT Supply Log in
Compliance orientation

EU vs USA Route for Private-Label Supplements

A side-by-side orientation to the EU food-supplement route and the US dietary-supplement route for a private-label launch. Covers how the product category, claims framework, label panel, pre-market step and documentation differ between the two — kept strictly separate.

EU vs USA Route for Private-Label Supplements
Reviewed formula concepts 149+
Launch routes White-label · Semi-custom · Custom
Project pathways EU · UK · US
Documentation 4 review gates by project stage

What this reference covers

  • EU food supplement vs US dietary supplement — the category difference
  • Claims frameworks — EFSA-authorised wording vs. structure-function claims
  • Label panels — EU NRV declaration vs. US Supplement Facts (%DV)
  • Pre-market step — member-state notification vs. facility registration
  • Documentation emphasis on each route

Who this is for

  • Brand teams launching a private-label supplement into both the EU and US
  • Operators moving an existing range across the Atlantic
  • Founders mapping the documentation and claim differences before the brief

This is an orientation reference, not a substitute for a regulatory consultant. The EU and US frameworks are kept separate and the final mapping is confirmed per project.

Launching into both markets?

Brief your order with both target markets and the team confirms the framework mapping and documentation route for each — EU and US separately.

EU and US route, side by side

Aspect EU food supplement US dietary supplement
Product category Food supplement under Directive 2002/46/EC — a foodstuff, not a medicine. Dietary supplement under DSHEA 1994 and the FD&C Act — a distinct category from drugs.
Claims framework Nutrition and health claims governed by Regulation (EC) 1924/2006; only EFSA-authorised wording (Reg. 432/2012) may be used. Disease claims are prohibited. Structure-function claims permitted without prior approval if substantiated and not misleading, with the DSHEA disclaimer. Disease claims are prohibited.
Label panel Mandatory particulars per Regulation 1169/2011; amounts declared against EU Nutrient Reference Values (NRV). Supplement Facts panel per 21 CFR 101.36; amounts declared against US Daily Values (%DV).
Pre-market step Member-state notification of the product on placing on the market (where the country requires it); UK/GB notified separately post-Brexit. No product pre-approval; facility registration and, for foreign sites, a US agent; new dietary ingredients may need an NDI notification.
Documentation emphasis Specification, EFSA claim mapping, allergen and NRV declaration, notification record. Specification, 21 CFR Part 111 GMP records, Supplement Facts artwork, structure-function substantiation file.

The two frameworks are independent and must never be combined on a single label. Framework mapping and claim wording are confirmed per project; final responsibility rests with the brand owner.

How this connects to your order brief

The brief captures your target markets. From there, the team maps the formula to each framework separately — the EU food-supplement route and the US dietary-supplement route — and confirms the documentation each requires. Where a single formula needs a market variant, that is settled per project.

Continue exploring

Ready to start an order?

The DAT Supply client workspace takes your order brief and routes it through the right manufacturing gate. Pick the route that matches where you are in planning.

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Order documents, certificates and pricing are released through the client workspace in the DAT portal.

You will receive a short confirmation email. Order documents (specification, batch-specific COA, packaging documents) are released through the client workspace in the DAT portal once a brief is in place.